Teduglutide is a recently introduced drug for Short Bowel Syndrome- What is it?
**Core Concept**
Teduglutide is a glucagon-like peptide-2 (GLP-2) analog, a type of gastrointestinal hormone that plays a crucial role in the regulation of intestinal growth and adaptation. GLP-2 is a naturally occurring peptide that stimulates intestinal growth, increases intestinal permeability, and enhances nutrient absorption.
**Why the Correct Answer is Right**
Teduglutide works by mimicking the action of GLP-2, promoting intestinal adaptation and growth in patients with short bowel syndrome (SBS). This leads to an increase in intestinal surface area, improved nutrient absorption, and reduced reliance on parenteral nutrition. Teduglutide has been shown to increase intestinal villous height, crypt depth, and villous surface area, thereby enhancing the absorptive capacity of the small intestine.
**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because teduglutide is not a somatostatin analog, which would inhibit gastrointestinal hormone secretion and potentially worsen SBS symptoms.
* **Option B:** This option is incorrect because teduglutide is not a prostaglandin analog, which would primarily affect gastric acid secretion and mucosal protection rather than intestinal growth and adaptation.
* **Option C:** This option is incorrect because teduglutide is not a corticosteroid, which would primarily affect inflammation and immune response rather than intestinal growth and adaptation.
**Clinical Pearl / High-Yield Fact**
Teduglutide is a novel therapeutic option for patients with short bowel syndrome who require parenteral nutrition, offering a potential solution to reduce or eliminate the need for long-term PN and improve quality of life.
**Correct Answer: C. A glucagon-like peptide-2 (GLP-2) analog.**